{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:33Z","timestamp":1792726713737,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["akdh.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.akdh.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:00:59Z","timestamp":1789678859000},"page":"199-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension Board Review"],"prefix":"10.1053","volume":"33","author":[{"given":"Sam","family":"Kant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.akdh.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.akdh.2024.09.001","article-title":"The nephrology boards and certification exams: a worldwide focus on excellence","volume":"31","author":"William","year":"2024","journal-title":"Adv Kidney Dis Health"},{"issue":"1","key":"10.1053\/j.akdh.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.akdh.2025.01.011","article-title":"The nephrology boards and certification exams: relevance in a changing landscape","volume":"32","author":"William","year":"2025","journal-title":"Adv Kidney Dis Health"},{"key":"10.1053\/j.akdh.2026.07.002_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1120009X.2021.1947022","article-title":"Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II\/III randomized controlled trials","volume":"34","author":"Yin","year":"2022","journal-title":"J Chemother"},{"key":"10.1053\/j.akdh.2026.07.002_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1053\/j.akdh.2026.07.002_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FJC.0b013e3181993493","article-title":"ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented rats","volume":"53","author":"Banfor","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.akdh.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1074\/jbc.M110.115311","article-title":"Vascular endothelial growth factor receptor-2 activates ADP-ribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells","volume":"285","author":"Daher","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.akdh.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00204-024-03874-4","article-title":"Hypertension toxicity of VEGFR-TKIs in cancer treatment: incidence, mechanisms, and management strategies","volume":"99","author":"Du","year":"2025","journal-title":"Arch Toxicol"},{"key":"10.1053\/j.akdh.2026.07.002_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.akdh.2026.07.002_bib8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.121.318051","article-title":"Hypertension and prohypertensive antineoplastic therapies in cancer patients","volume":"128","author":"van Dorst","year":"2021","journal-title":"Circ Res"},{"key":"10.1053\/j.akdh.2026.07.002_bib9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/HJH.0000000000002349","article-title":"Kidney-specific lymphangiogenesis increases sodium excretion and lowers blood pressure in mice","volume":"38","author":"Balasubbramanian","year":"2020","journal-title":"J Hypertens"},{"key":"10.1053\/j.akdh.2026.07.002_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jnci\/djq091","article-title":"Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors","volume":"102","author":"Maitland","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.akdh.2026.07.002_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.ackd.2021.09.011","article-title":"Onco-hypertension: an emerging specialty","volume":"28","author":"Gudsoorkar","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.akdh.2026.07.002_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1053\/j.akdh.2026.07.002_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1053\/j.akdh.2026.07.002_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.ajkd.2019.03.427","article-title":"Physiology and pathophysiology of potassium homeostasis: core curriculum 2019","volume":"74","author":"Palmer","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.164.14.1561","article-title":"Laboratory tests to determine the cause of hypokalemia and paralysis","volume":"164","author":"Lin","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.akdh.2026.07.002_bib16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.akdh.2026.07.002_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/HJH.0000000000002398","article-title":"Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals","volume":"38","author":"Lawson","year":"2020","journal-title":"J Hypertens"},{"key":"10.1053\/j.akdh.2026.07.002_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"key":"10.1053\/j.akdh.2026.07.002_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajh\/hpae059","article-title":"Effect of therapeutic drug monitoring on adherence and blood pressure: a multicenter randomized clinical trial","volume":"37","author":"Halvorsen","year":"2024","journal-title":"Am J Hypertens"},{"key":"10.1053\/j.akdh.2026.07.002_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.akdh.2026.07.002_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ijcp.12591","article-title":"Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker\/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study","volume":"69","author":"Hsu","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.akdh.2026.07.002_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp060434","article-title":"Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents","volume":"64","author":"Gerbino","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.akdh.2026.07.002_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/2013.jamainternmed.717","article-title":"Automated outreach to increase primary adherence to cholesterol-lowering medications","volume":"173","author":"Derose","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.akdh.2026.07.002_bib25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2024.18080","article-title":"Low-dose triple-pill vs standard-care protocols for hypertension treatment in Nigeria: a randomized clinical trial","volume":"332","author":"Ojji","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1053\/j.akdh.2026.07.002_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jhm.804","article-title":"Prevalence and management of hypertension in the inpatient setting: a systematic review","volume":"6","author":"Axon","year":"2011","journal-title":"J Hosp Med"},{"issue":"1","key":"10.1053\/j.akdh.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamainternmed.2024.6213","article-title":"As-needed blood pressure medication and adverse outcomes in VA hospitals","volume":"185","author":"Canales","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1053\/j.akdh.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamainternmed.2019.3007","article-title":"Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge","volume":"179","author":"Anderson","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1053\/j.akdh.2026.07.002_bib30","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1161\/HYP.0000000000000238","article-title":"The management of elevated blood pressure in the acute care setting: a scientific statement from the American heart Association","volume":"81","author":"Bress","year":"2024","journal-title":"Hypertension"},{"issue":"6","key":"10.1053\/j.akdh.2026.07.002_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.akdh.2026.07.002_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1472-6963-12-270","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss","volume":"12","author":"Meddings","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1053\/j.akdh.2026.07.002_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcp.12194","article-title":"What are validated self-report adherence scales really measuring?: a systematic review","volume":"77","author":"Nguyen","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1053\/j.akdh.2026.07.002_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11906-015-0579-4","article-title":"Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension","volume":"17","author":"Ruzicka","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1053\/j.akdh.2026.07.002_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF03256649","article-title":"The role of DOTS in tuberculosis treatment and control","volume":"2","author":"Davies","year":"2003","journal-title":"Am J Respir Med"},{"issue":"10","key":"10.1053\/j.akdh.2026.07.002_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamainternmed.2019.1455","article-title":"Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension","volume":"179","author":"Ruzicka","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1053\/j.akdh.2026.07.002_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jhh.2015.38","article-title":"Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic","volume":"30","author":"Hameed","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1053\/j.akdh.2026.07.002_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/HYPERTENSIONAHA.118.12079","article-title":"Comparison of automated office blood pressure with office and out-off-office measurement techniques","volume":"73","author":"Pappaccogli","year":"2019","journal-title":"Hypertension"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:02:07Z","timestamp":1792724527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813926000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2949813926000820"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2026.07.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension Board Review","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}